MYCO.NE Stock - Mydecine Innovations Group Inc.
Unlock GoAI Insights for MYCO.NE
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $7,493 | $2,617 |
| Gross Profit | N/A | N/A | N/A | $7,493 | $21,120 |
| Gross Margin | N/A | N/A | N/A | 100.0% | 807.0% |
| Operating Income | $-2,485,069 | $-9,382,577 | $-15,708,947 | $-22,099,182 | $-11,207,630 |
| Net Income | $-3,152,136 | $-20,947,032 | $-11,566,676 | $-28,897,399 | $-26,948,945 |
| Net Margin | N/A | N/A | N/A | -385658.6% | -1029764.8% |
| EPS | $-0.05 | $-0.68 | $-1.82 | $-5.04 | $-11.85 |
Mydecine Innovations Group Inc., a biotech and life sciences company, engages in the development and commercialization of drugs for treating mental health problems. It develops therapies for veterans, emergency medical service providers, post-traumatic stress disorder, and front-line workers; and operates Mindleap, a digital telehealth platform that provides access to mental health services, as well as psychedelic integration services, including psychedelic aftercare and wellness services. The company also engages in the drug discovery and builds nature-sourced psychedelic-assisted therapeutics, compounds, therapy protocols, and unique delivery systems. In addition, it operates hemp farm in Pottus, Texas. Mydecine Innovations Group Inc. has a partnership with Leiden University Medical Center; Royal Ottawa Mental Health Centre; LeadGen Labs to support psychedelic drug development; and Applied Pharmaceutical Innovation for drug development and clinical trial programs. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Visit WebsiteEarnings History & Surprises
MYCO.NEEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 17, 2025 | — | — | — | — |
Q3 2024 | Aug 12, 2024 | — | $-0.04 | — | — |
Q2 2024 | May 13, 2024 | — | $-0.02 | — | — |
Q1 2024 | Mar 29, 2024 | — | $-0.18 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.04 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.10 | — | — |
Q1 2023 | Mar 30, 2023 | — | $-0.41 | — | — |
Q1 2023 | Mar 29, 2023 | — | $-0.33 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.35 | — | — |
Q3 2022 | Aug 15, 2022 | $-1.00 | $-0.35 | +65.0% | ✓ BEAT |
Q2 2022 | May 16, 2022 | $-1.00 | $-1.20 | -20.0% | ✗ MISS |
Q1 2022 | Mar 30, 2022 | $-1.00 | $-75.00 | -7400.0% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | $-0.50 | $-1.00 | -100.0% | ✗ MISS |
Q3 2021 | Aug 16, 2021 | $-1.00 | $-1.00 | 0.0% | = MET |
Q2 2021 | May 17, 2021 | — | $-1.25 | — | — |
Q2 2021 | Apr 30, 2021 | — | $-2.96 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-3.74 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-1.77 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.29 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-1.97 | — | — |
Latest News
Frequently Asked Questions about MYCO.NE
What is MYCO.NE's current stock price?
What is the analyst price target for MYCO.NE?
What sector is Mydecine Innovations Group Inc. in?
What is MYCO.NE's market cap?
Does MYCO.NE pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MYCO.NE for comparison